HOW CAN WE USE NEUROTRANSMITTERS IN EMOTION AND REWARD SYSTEM TO STUDY DEPRESSION?
DOI:
https://doi.org/10.20319/lijhls.2019.53.4162Keywords:
Depression, Emotion, Monoamine Neurotransmitter, Antidepressant Drug, Side EffectsAbstract
Depression is the most common and widespread psychiatric disorder severely affecting people’s lives at all ages. Factors from social, psychological, and biological aspects can contribute to depression, and many hypotheses are associated with biological factors involved in the aetiology of depression such as genes and neurotransmitters. As three monoamine neurotransmitters, dopamine, serotonin, and norepinephrine, are involved in the regulation of mood and motivation in emotion and reward system, the dysfunction of neurotransmitters of depressive patients can lead to their abnormal symptoms. This paper will discuss how the behaviour of these neurotransmitters has helped develop antidepressant drugs for treating depression. Although helpful, antidepressant drugs have other negative health outcomes on users such as side effects. Research on antidepressants has led to the development of new drugs such as nasal spray and skin patch which has shown to alleviate symptoms of depressive patients. Current treatments with a potential reduction of side effects are suggested on new applications for improving public health condition. Furthermore, other non-medical factors such as social engagement and physical activity are also involved in treating depression.
References
Aan het Rot, M., Mathew, S.J. and Charney, D.S. (2009). Neurobiological Mechanisms in Major Depressive Disorder. Canadian Medical Association Journal, 180(3), pp.305–313. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630359/ https://doi.org/10.1503/cmaj.080697
Admon, R. and Pizzagalli, D.A. (2015). Dysfunctional Reward Processing in Depression. Current Opinion in Psychology, 4, pp.114–118. https://doi.org/10.1016/j.copsyc.2014.12.011
Alan, S., Bakir, E., Surucu, S.G., & Yildirim, E. (2018). Identify Menstruation Related Problems and Suicide. LIFE: International Journal of Health and Life-Sciences, 3(3). Retrieved from https://grdspublishing.org/index.php/life/article/view/1146 https://doi.org/10.20319/lijhls.2018.33.168178
Andrade, C. and Rao, S.K. (2010). How Antidepressant Drugs act: a Primer on Neuroplasticity as the Eventual Mediator of Antidepressant Efficacy. Indian Journal of Psychiatry, 52(4), p.378. https://doi.org/10.4103/0019-5545.74318
Asnis, G. and Henderson, M. (2014). EMSAM (deprenyl patch): How a Promising Antidepressant was underutilized [Corrigendum]. Neuropsychiatric Disease and Treatment, p.2069. https://doi.org/10.2147/NDT.S59107 https://doi.org/10.2147/NDT.S75736
Baghai, T., Moller, H.-J. and Rupprecht, R. (2006). Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression. Current Pharmaceutical Design, 12(4), pp.503–515. https://doi.org/10.2174/138161206775474422
Banerjee, S. P., Kung, L. S., Riggi, S. J., & Chanda, S. K. (1977). Development of β-adrenergic receptor subsensitivity by antidepressants. Nature, 268(5619), 455. https://doi.org/10.1038/268455a0
Barnes, N. M., & Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology, 38(8), 1083-1152. https://doi.org/10.1016/S0028-3908(99)00010-6
Beauchaine, T.P., Klein, D.N., Knapton, E. and Zisner, A. (2019). Anhedonia in Depression: Mechanisms, Assessment, and Therapeutics. Neurobiology of Depression, pp.31–41. https://doi.org/10.1016/S0028-3908(99)00010-6
Belmaker, R.H. and Agam, G. (2008). Major Depressive Disorder. New England Journal of Medicine, 358(1), pp.55–68. https://doi.org/10.1056/NEJMra073096
Blier, P. (2016). Neurobiology of Depression and Mechanism of Action of Depression Treatments. The Journal of Clinical Psychiatry, 77(03), pp.e319–e319. https://doi.org/10.4088/JCP.13097tx3c
Bönisch, H., Sitte, H. H., & Bönisch. (2016). Neurotransmitter Transporters. Springer Science+ Business Media New York. https://doi.org/10.1007/978-1-4939-3765-3
Briere, J., Kwon, O., Semple, R.J. and Godbout, N. (2019). Recent Suicidal Ideation and Behavior in the General Population. The Journal of Nervous and Mental Disease, 207(5), pp.320–325. https://doi.org/10.1097/NMD.0000000000000976
Briguglio, M., Dell’Osso, B., Panzica, G., Malgaroli, A., Banfi, G., Zanaboni Dina, C., Galentino, R. and Porta, M. (2018). Dietary Neurotransmitters: a Narrative Review on Current Knowledge. Nutrients, 10(5), p.591. https://doi.org/10.3390/nu10050591
Briley, M. and Chantal, M. (2011). The importance of norepinephrine in depression. Neuropsychiatric Disease and Treatment, p.9. https://doi.org/10.2147/NDT.S19619
Cacioppo, J.T., Hughes, M.E., Waite, L.J., Hawkley, L.C. and Thisted, R.A. (2006). Loneliness as a Specific Risk Factor for Depressive symptoms: Cross-sectional and Longitudinal analyses. Psychology and Aging, 21(1), pp.140–151. https://doi.org/10.1037/0882-7974.21.1.140
Caligiuri, M. P., & Ellwanger, J. (2000). Motor and cognitive aspects of motor retardation in depression. Journal of Affective Disorders, 57(1-3), 83–93. doi:10.1016/s0165-0327(99)00068-3 https://doi.org/10.1016/S0165-0327(99)00068-3
Carlson, N.R. and Birkett, M.A. (2017). Physiology of Behavior. Harlow, Essex: Pearson.
Chakrabarti, S. and Mohanakumar, K.P. (2016). Aging and Neurodegeneration: a Tangle of Models and Mechanisms. Aging and Disease, 7(2), p.111. https://doi.org/10.14336/AD.2016.0312
Chow, W., Doane, M.J., Sheehan, J., Alphs, L. and Le, H. (2019). Economic Burden among Patients with Major Depressive Disorder: An Analysis of Healthcare Resource Use, Work Productivity, and Direct and Indirect Costs by Depression Severity. AJMC. Available at: https://www.ajmc.com/journals/supplement/2019/economic-burden-mdd-analysis-healthcare/economic-burden-mdd
Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S. E., Qin, B., Whittington, C., … Xie, P. (2016, August 27). Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27289172
Comijs, H.C., van Exel, E., van der Mast, R.C., Paauw, A., Oude Voshaar, R. and Stek, M.L. (2013). Childhood Abuse in late-life Depression. Journal of Affective Disorders, 147(1–3), pp.241–246. https://doi.org/10.1016/j.jad.2012.11.010
Davies, F.R. and Morris, B.J. (2006). Molecular Biology of the Neuron. Oxford ; New York: Oxford University Press. https://doi.org/10.1016/j.jmb.2006.05.039 https://doi.org/10.1016/j.jmb.2006.01.022 https://doi.org/10.1016/j.jmb.2006.02.072
Dean, J. and Keshavan, M. (2017). The Neurobiology of depression: an Integrated View. Asian Journal of Psychiatry, 27, pp.101–111. https://doi.org/10.1016/j.ajp.2017.01.025
Der-Avakian, A. and Markou, A. (2012). The Neurobiology of Anhedonia and Other reward-related Deficits. Trends in Neurosciences, 35(1), pp.68–77. https://doi.org/10.1016/j.tins.2011.11.005
Elias, L. J, & Saucier, D. M. (2005). Neuropsychology: Clinical and Experimental Foundations. Boston: Pearson
Elliott, W. and Chan, J. (2019). Esketamine Nasal Spray (Spravato) CIII. Retrieved from https://www.reliasmedia.com/articles/144249-esketamine-nasal-spray-spravato-ciii
Emsam.com. (2017). Major Depressive Disorder Treatment | EMSAM®. Retrieved from http://Emsam.com [Accessed 20 Jul. 2019]
Fakhoury, M. (2015). Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders. Molecular Neurobiology, 53(5), 2778–2786. https://doi.org/10.1007/s12035-015-9152-z
Firth, J., Marx, W., Dash, S., Carney, R., Teasdale, S.B., Solmi, M., Stubbs, B., Schuch, F.B., Carvalho, A.F., Jacka, F. and Sarris, J. (2019). The Effects of Dietary Improvement on Symptoms of Depression and Anxiety. Psychosomatic Medicine, 81(3), pp.265–280. https://doi.org/10.1097/PSY.0000000000000673
Fischer, A.G. and Ullsperger, M. (2017). An Update on the Role of Serotonin and its Interplay with Dopamine for Reward. Frontiers in Human Neuroscience, 11. https://doi.org/10.3389/fnhum.2017.00484
Fon, E. A., & Edwards, R. H. (2001). Molecular mechanisms of neurotransmitter release. Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine, 24(5), 581-601. https://doi.org/10.1002/mus.1044
Foong, A.-L., Grindrod, K.A., Patel, T. and Kellar, J. (2018). Demystifying serotonin syndrome (or serotonin toxicity). Canadian family physician Medecin de famille canadien, 64(10), pp.720–727. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30315014
Frank, C. (2008). Recognition and treatment of serotonin syndrome. Canadian family physician Medecin de famille canadien, 54(7), pp.988–92. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464814/
Freeman, A., Tyrovolas, S., Koyanagi, A., Chatterji, S., Leonardi, M., Ayuso-Mateos, J.L., Tobiasz-Adamczyk, B., Koskinen, S., Rummel-Kluge, C. and Haro, J.M. (2016). The role of socio-economic status in depression: results from the COURAGE (aging survey in Europe). BMC Public Health, 16(1). https://doi.org/10.1186/s12889-016-3638-0
García-Cazorla, À., & Artuch, R. (2015). Neurotransmitter Disorders. Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease, 703–712. https://doi.org/10.1016/B978-0-12-410529-4.00063-2
Gerke, J., Koenig, A.M., Conrad, D., Doyen-Waldecker, C., Pauly, M., Gündel, H., Wilker, S. and Kolassa, I.-T. (2018). Childhood maltreatment as risk factor for lifetime depression: The role of different types of experiences and sensitive periods. Mental Health & Prevention, 10, pp.56–65. https://doi.org/10.1016/j.mhp.2018.03.002
Goldstein-Piekarski, A. N., & Williams, L. M. (2019). A Neural Circuit-Based Model for Depression Anchored in a Synthesis of Insights From Functional Neuroimaging. Neurobiology of Depression, 241–256. https://doi.org/10.1016/B978-0-12-813333-0.00021-4
Hamon, M. and Blier, P. (2013). Monoamine neurocircuitry in depression and strategies for new treatments. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 45, pp.54–63. https://doi.org/10.1016/j.pnpbp.2013.04.009
Harmer, C. J., Duman, R. S., & Cowen, P. J. (2017). How do antidepressants work? New perspectives for refining future treatment approaches. The Lancet Psychiatry, 4(5), 409-418. https://doi.org/10.1016/S2215-0366(17)30015-9
Hasler, G. (2010). Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry: Official Journal of the World Psychiatric Association (WPA), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950973/ https://doi.org/10.1002/j.2051-5545.2010.tb00298.x
Howard, D.M., Adams, M.J., Clarke, T.-K., Hafferty, J.D., Gibson, J., Shirali, M., Coleman, J.R.I., Hagenaars, S.P., Ward, J., Wigmore, E.M., Alloza, C., Shen, X., Barbu, M.C., Xu, E.Y., Whalley, H.C., Marioni, R.E., Porteous, D.J., Davies, G., Deary, I.J., Hemani, G., Berger, K., Teismann, H., Rawal, R., Arolt, V., Baune, B.T., Dannlowski, U., Domschke, K., Tian, C., Hinds, D.A., Trzaskowski, M., Byrne, E.M., Ripke, S., Smith, D.J., Sullivan, P.F., Wray, N.R., Breen, G., Lewis, C.M. and McIntosh, A.M. (2019). Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nature Neuroscience, 22(3), pp.343–352. https://doi.org/10.1038/s41593-018-0326-7
Isbister, G.K., Bowe, S.J., Dawson, A. and Whyte, I.M. (2004). Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose. Journal of Toxicology: Clinical Toxicology, 42(3), pp.277–285. https://doi.org/10.1081/CLT-120037428
Jaso, B., Niciu, M., Iadarola, N., Lally, N., Richards, E., Park, M., Ballard, E., Nugent, A., Machado-Vieira, R. and Zarate, C. (2016). Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder. Current Neuropharmacology, 15(1), pp.57–70. https://doi.org/10.2174/1570159X14666160321123221
Jennings, L. (2018). Antidepressants. Clinical Psychopharmacology for Neurologists, pp.45–71. https://doi.org/10.1007/978-3-319-74604-3_4
Karg, K., Burmeister, M., Shedden, K. and Sen, S. (2011). The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited. Archives of General Psychiatry, 68(5), p.444. ttps://doi.org/10.1001/archgenpsychiatry.2010.189
Kim, J., Farchione, T., Potter, A., Chen, Q. and Temple, R. (2019). Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class. New England Journal of Medicine, 381(1), pp.1–4. https://doi.org/10.1056/NEJMp1903305
Krishnan, K. (2009). Monoamine Oxidase Inhibitors. The American Psychiatric Publishing Textbook of Psychopharmacology. https://doi.org/10.1176/appi.books.9781585623860.as18
Lam, R.W., Kennedy, S.H., McIntyre, R.S. and Khullar, A. (2014). Cognitive Dysfunction in Major Depressive Disorder: Effects on Psychosocial Functioning and Implications for Treatment. The Canadian Journal of Psychiatry, 59(12), pp.649–654. https://doi.org/10.1177/070674371405901206
Lin, T.-W. and Kuo, Y.-M. (2013). Exercise Benefits Brain Function: the Monoamine Connection. Brain Sciences, 3(4), pp.39–53. https://doi.org/10.3390/brainsci3010039
Lodish, H.F. and National Library of Medicine (2000). Molecular Cell Biology. 4th ed. New York: W.H. Freeman; Basingstoke.
López-Muñoz, F., Álamo, C., Juckel, G. and Assion, H.-J. (2007). Half a Century of Antidepressant Drugs. Journal of Clinical Psychopharmacology, 27(6), pp.555–559. https://doi.org/10.1097/jcp.0b013e3181bb617
Mathew, B., E Mathew, G., Suresh, J., Ucar, G., Sasidharan, R., Anbazhagan, S., ... & Jayaprakash, V. (2016). Monoamine oxidase inhibitors: Perspective design for the treatment of depression and neurological disorders. Current Enzyme Inhibition, 12(2), 115-122. https://doi.org/10.2174/1573408012666160402001715
MELTZER, H.Y. (1990). Role of Serotonin in Depression. Annals of the New York Academy of Sciences, 600(1 The Neurophar), pp.486–499. https://doi.org/10.1111/j.1749-6632.1990.tb16904.x
Naranjo, C.A., Tremblay, L.K. and Busto, U.E. (2001). The role of the brain reward system in depression. Progress in neuro-psychopharmacology & biological psychiatry, 25(4), pp.781–823. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11383978. https://doi.org/10.1016/S0278-5846(01)00156-7
National Institute of Mental Health (2019). Depression. Retrieved from https://www.nimh.nih.gov/health/topics/depression/index.shtml
Nautiyal, K.M., Tritschler, L., Ahmari, S.E., David, D.J., Gardier, A.M. and Hen, R. (2016). A Lack of Serotonin 1B Autoreceptors Results in Decreased Anxiety and Depression-Related Behaviors. Neuropsychopharmacology, 41(12), pp.2941–2950. https://doi.org/10.1038/npp.2016.109
Neve, K. (Ed.). (2009). The dopamine receptors. Springer Science & Business Media.
Noerhidajati, E.,Makarim, F. R.,& Albab, A. U. (2018). Stress, Anxiety, and Depression Relationship among Undergraduate Medical Students and Their Final Exam Mark. LIFE: International Journal of Health and Life-Sciences, 4(3), 26-37 https://doi.org/10.20319/lijhls.2018.43.2637
Nordqvist, C. (2018). Antidepressants: Types, side effects, uses, and effectiveness. Medical News Today. Available at: https://www.medicalnewstoday.com/kc/antidepressants-work-248320
Paykel, E.S. (2008). Basic concepts of depression. Dialogues in clinical neuroscience, 10(3), pp.279–89. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181879/
Pizzagalli, D. A., Holmes, A. J., Dillon, D. G., Goetz, E. L., Birk, J. L., Bogdan, R., … Fava, M. (2009). Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Individuals with Major Depressive Disorder. American Journal of Psychiatry, 166(6), 702–710. https://doi.org/10.1176/appi.ajp.2008.08081201
Popova, V., Daly, E.J., Trivedi, M., Cooper, K., Lane, R., Lim, P., Mazzucco, C., Hough, D., Thase, M.E., Shelton, R.C., Molero, P., Vieta, E., Bajbouj, M., Manji, H., Drevets, W.C. and Singh, J.B. (2019). Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined with a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: a Randomized Double-Blind Active-Controlled Study. American Journal of Psychiatry, 176(6), pp.428–438. https://doi.org/10.1176/appi.ajp.2019.19020172
Ruhé, H.G., Mason, N.S. and Schene, A.H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Molecular Psychiatry, 12(4), pp.331–359. https://doi.org/10.1038/sj.mp.4001949
Salamone, J.D. and Correa, M. (2012). The Mysterious Motivational Functions of Mesolimbic Dopamine. Neuron, 76(3), pp.470–485. https://doi.org/10.1016/j.neuron.2012.10.021
Santini, Z.I., Koyanagi, A., Tyrovolas, S., Mason, C. and Haro, J.M. (2015). The Association between Social Relationships and depression: a Systematic Review. Journal of Affective Disorders, 175, pp.53–65. https://doi.org/10.1016/j.jad.2014.12.049
Sarris, J., O’Neil, A., Coulson, C.E., Schweitzer, I. and Berk, M. (2014). Lifestyle Medicine for Depression. BMC Psychiatry, 14(1). https://doi.org/10.1186/1471-244X-14-107
Schotte, C.K.W., Van Den Bossche, B., De Doncker, D., Claes, S. and Cosyns, P. (2006). A biopsychosocial model as a guide for psychoeducation and treatment of depression. Depression and Anxiety, 23(5), pp.312–324. https://doi.org/10.1002/da.20177
Shadrina, M., Bondarenko, E.A. and Slominsky, P.A. (2018). Genetics Factors in Major Depression Disease. Frontiers in Psychiatry, 9. https://doi.org/10.3389/fpsyt.2018.00334
Shankman, S.A., Gorka, S.M., Katz, A.C., Klein, D.N., Markowitz, J.C., Arnow, B.A., Manber, R., Rothbaum, B.O., Thase, M.E., Schatzberg, A.F., Keller, M.B., Trivedi, M.H. and Kocsis, J.H. (2017). Side Effects to Antidepressant Treatment in Patients with Depression and Comorbid Panic Disorder. The Journal of Clinical Psychiatry, 78(04), pp.433–440. https://doi.org/10.4088/JCP.15m10370
Smith, M. (2019, November 5). Depression Symptoms and Warning Signs. Retrieved from https://www.helpguide.org/articles/depression/depression-symptoms-and-warning-signs.htm
Spravato® (esketamine). (2019). Starting SpravatoTM. Retrieved from https://www.spravatohcp.com/starting-spravato
Steven D., H. (2011). Cognitive and Behavior Therapy in the Treatment and Prevention of Depression. Depression and Anxiety, 28(4), pp.263–266. https://doi.org/10.1002/da.20797
Tank, A.W. and Lee Wong, D. (2015). Peripheral and central effects of circulating catecholamines. Comprehensive Physiology, 5(1), pp.1–15. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25589262. https://doi.org/10.1002/cphy.c140007
Timmermans, P.B.M.W.M. and Thoolen, M.J.M.C. (1987). Autoreceptors in the Central Nervous System. Medicinal Research Reviews, 7(3), pp.307–332. https://doi.org/10.1002/med.2610070303
U.S. Food & Drug Administration (2019). Janssen Presentations for the February 12, 2019 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee | FDA. Retrieved from https://www.fda.gov/media/121379
Wacker, J., Dillon, D.G. and Pizzagalli, D.A. (2009). The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: Integration of resting EEG, fMRI, and volumetric techniques. NeuroImage, 46(1), pp.327–337. https://doi.org/10.1016/j.neuroimage.2009.01.058
Weilburg, J.B. (2004). An overview of SSRI and SNRI therapies for depression. Managed Care (Langhorne, Pa.), 13(6 Suppl Depression), pp.25–33. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/15293768
Wikimedia.org. (2006). File:SynapseIllustration2.png - Wikimedia Commons. Retrieved from https://commons.wikimedia.org/wiki/File:SynapseIllustration2.png
Wikimedia.org. (2015). File:Dopaminergic pathways.svg - Wikimedia Commons. Retrieved from https://commons.wikimedia.org/wiki/File:Dopaminergic_pathways.svg
World Health Organisation (2018). Depression. Who.int. Retrieved from https://www.who.int/news-room/fact-sheets/detail/depression
Wurtman, R. J., Hefti, F., & Melamed, E. (1980). Precursor control of neurotransmitter synthesis. Pharmacological Reviews, 32(4), 315-335.
Zhou, X., Cipriani, A., Furukawa, T.A., Cuijpers, P., Zhang, Y., Hetrick, S.E., Pu, J., Yuan, S., Del Giovane, C. and Xie, P. (2018). Comparative Efficacy and Tolerability of new-generation Antidepressants for Major Depressive Disorder in Children and adolescents: Protocol of an Individual Patient Data meta-analysis. BMJ Open, 8(1), p.e018357. https://doi.org/10.1136/bmjopen-2017-018357
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of Published Articles
Author(s) retain the article copyright and publishing rights without any restrictions.
All published work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
